Inventiva CEO: Phase 3 Lanifibranor MASH Trial Fully Enrolled, Top-Line Data Due in H2

CEO Andrew Obenshain said the company is preparing for a second-half phase 3 readout for lanifibranor in metabolic dysfunction-associated steatohepatitis (MASH), describing the trial as fully enrolled ...
The Lancet

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of adults, with about 30% of cases progressing to metabolic dysfunction-associated steatohepatitis (MASH), ...
Amazon S3 on MSN

Discover how to use the secret F13 F24 keyboard keys effectively

Tech expert ThioJoe explains why function keys from F13 to F24 exist and how they can still be used.

Black homeownership is declining. Why?

Redfin Real Estate reports that homeownership among Black Gen Zers and millennials is declining, while it rises for their ...